Evidence map›Paper›PMID 41063363›Full record

ArticleAIDS care2025

Staff perspectives on using long-acting antiretroviral treatment among persons being released from carceral settings in Baltimore, Maryland, USA.

Zaire Cullins, Aurielle Thomas, Curt G Beckwith, Michael Gordon, Thomas Blue, Christian Black, Hannah Camp, Lauren Brinkley-Rubinstein

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zaire CullinsDepartment of Population Health Sciences, Duke University, Durham, NC, USA.
Aurielle ThomasDivision of Infectious Diseases, The Miriam Hospital, Providence, RI, USA.
Curt G BeckwithDivision of Infectious Diseases, The Miriam Hospital, Providence, RI, USA.
Michael GordonFriends Research Institute, Inc., Baltimore, MD, USA.
Thomas BlueFriends Research Institute, Inc., Baltimore, MD, USA.
Christian BlackCenter for Environmental Health Disparities, University of California, Irvine, Irvine, CA, USA.
Hannah CampDepartment of Population Health Sciences, Duke University, Durham, NC, USA.
Lauren Brinkley-RubinsteinDepartment of Population Health Sciences, Duke University, Durham, NC, USA.

Funding

Long-acting injectable antiretroviral treatment to improve HIV treatment among justice-involved persons being released to the communityR34DA057165 · NIDA · MIRIAM HOSPITAL · PI BECKWITH, CURT G, BRINKLEY-RUBINSTEIN, LAUREN · 2022 to 2024
$717k
NIDA NIH HHS R34 DA057165
6 · The paper itself

Abstract

The prevalence of HIV among individuals who experience incarceration is estimated to be three times higher than that of the general population in the United States. Currently, the standard of care, antiretroviral medications taken daily, is effective in reducing mortality and HIV transmission but individuals experiencing community re-entry face barriers while re-integrating with their community which may make adherence to daily medication challenging. Long acting injectable antiretroviral treatment (LAI ART) may offer an opportunity for individuals experiencing community re-entry to remain in treatment while prioritizing their other needs. Our team conducted 16 interviews with various staff in both community and carceral settings pertaining to the potential administration of LAI ART in prison settings with treatment continuing while individuals are experiencing community re-entry. Many participants were supportive of administering LAI ART in this population, but challenges related to ensuring continuation of care, access to clinics, and the lack of resources in health settings were frequently cited as potential barriers.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsAttitude of Health PersonnelHIV InfectionsPrisonersPrisonsAdultBaltimoreDelayed-Action PreparationsFemaleHealth Services AccessibilityHumansInterviews as TopicMaleMedication AdherenceMiddle AgedAnti-HIV AgentsAnti-Retroviral AgentsDelayed-Action Preparationscriminal legal systemHIV treatmentLong acting injectablesSDG 10: Reduced inequalitiesSDG 3: Good health and well-being

Identifiers

PMID41063363
PMCPMC12810683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.